GR3036836T3 - Sulfur-containing heterocyclic compounds. - Google Patents

Sulfur-containing heterocyclic compounds.

Info

Publication number
GR3036836T3
GR3036836T3 GR20010401697T GR20010401697T GR3036836T3 GR 3036836 T3 GR3036836 T3 GR 3036836T3 GR 20010401697 T GR20010401697 T GR 20010401697T GR 20010401697 T GR20010401697 T GR 20010401697T GR 3036836 T3 GR3036836 T3 GR 3036836T3
Authority
GR
Greece
Prior art keywords
sulfur
containing heterocyclic
heterocyclic compounds
optionally substituted
ring
Prior art date
Application number
GR20010401697T
Other languages
English (en)
Inventor
Takashi Sohda
Iwao Yamazaki
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GR3036836T3 publication Critical patent/GR3036836T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655381Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
    • C07F9/65539Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR20010401697T 1990-05-30 2001-10-08 Sulfur-containing heterocyclic compounds. GR3036836T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14194390 1990-05-30

Publications (1)

Publication Number Publication Date
GR3036836T3 true GR3036836T3 (en) 2002-01-31

Family

ID=15303749

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401697T GR3036836T3 (en) 1990-05-30 2001-10-08 Sulfur-containing heterocyclic compounds.

Country Status (8)

Country Link
EP (1) EP0460488B1 (el)
JP (2) JP2992653B2 (el)
AT (1) ATE203020T1 (el)
CA (1) CA2043468A1 (el)
DE (1) DE69132651T2 (el)
DK (1) DK0460488T3 (el)
ES (1) ES2157887T3 (el)
GR (1) GR3036836T3 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008517A2 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
CA2191980A1 (en) * 1994-07-04 1996-01-18 Takashi Sohda Phosphonic acid compounds, their production and use
TW403757B (en) 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
NZ308658A (en) * 1995-06-05 1999-10-28 Takeda Chemical Industries Ltd Sustained release synergistic pharmaceutical composition comprising a non-peptide osteogenetic promoting substance and a biodegradable polymer
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
EP0842179A1 (en) * 1995-07-24 1998-05-20 Takeda Chemical Industries, Ltd. Production of optically active benzothiepin salts
AU4571097A (en) * 1996-10-09 1998-05-05 Takeda Chemical Industries Ltd. A method for producing a microparticle
CA2334815A1 (en) * 1998-06-15 1999-12-23 Haruhiko Makino Composition for treating cartilage disease
EP1103552A4 (en) 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
EP1105140A2 (en) * 1998-08-12 2001-06-13 Takeda Chemical Industries, Ltd. Benzothiepine compounds as enhancer of cell differentiation induction factor
AU4145200A (en) * 1999-05-07 2000-11-21 Takeda Chemical Industries Ltd. Cyclic compounds and uses thereof
CA2447618A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. A composition for regenerative treatment of cartilage disease
CN1520313A (zh) 2001-05-23 2004-08-11 ������ҩ��ʽ���� 一种加速骨折愈合的组合物
EP1974754A4 (en) 2006-01-18 2012-09-05 Nat Univ Corp Tokyo Med & Dent BIOMATERIALS FOR THE OSTEOGENESIS WITH AN ESTEOGENESIS PROMOTER AND A NANOGEL
KR102062762B1 (ko) * 2017-10-18 2020-01-06 이경민 반죽을 수제비 형상으로 성형하는 성형장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636049A (en) * 1969-11-26 1972-01-18 Pfizer Isothiochroman carboxamides
NZ231939A (en) * 1988-12-28 1991-07-26 Takeda Chemical Industries Ltd Benzothiopyran derivatives and medicaments

Also Published As

Publication number Publication date
CA2043468A1 (en) 1991-12-01
EP0460488B1 (en) 2001-07-11
ATE203020T1 (de) 2001-07-15
JPH09176154A (ja) 1997-07-08
JP3165889B2 (ja) 2001-05-14
EP0460488A1 (en) 1991-12-11
JPH04364179A (ja) 1992-12-16
ES2157887T3 (es) 2001-09-01
DE69132651T2 (de) 2001-10-25
JP2992653B2 (ja) 1999-12-20
DE69132651D1 (de) 2001-08-16
DK0460488T3 (da) 2001-09-17

Similar Documents

Publication Publication Date Title
EP0422596A3 (en) Tricyclic carbapenem compounds
GR3036836T3 (en) Sulfur-containing heterocyclic compounds.
NO940550L (el)
AU1929088A (en) Polyethylene glycol carbamates
TW290546B (el)
GB8920521D0 (en) New compositions of matter
TW256832B (el)
HK17396A (en) Sulfur-containing heterocyclic compounds
AU2321688A (en) Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
EP0538969A3 (el)
AU4983790A (en) Aralkylamine compounds
EP0601191A4 (en) Novel tetracyclic compound.
PT83334A (en) Process for the preparation of beta-lactam compounds
AU3006689A (en) Process for the diacylation of compounds containing two aromatic rings
WO1999065474A3 (en) Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
ZA899821B (en) Novel compounds
EP0791581A4 (en) UCH 15 STRAIN COMPOUNDS
EP0609457A4 (en) Benzene derivative.
WO2000009100A3 (en) Benzothiepine compounds as enhancer of cell differentiation induction factor
AU8488391A (en) Piperazine derivatives

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees